Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-01

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trigger finger is the common name of stenosing tenosynovitis of fingers, caused by repetitive trauma. Conservative treatment includes NSAIDs or other analgesic agents, activity modification, splint, and physiotherapy. Operation could be considered if conservative treatments fails. With literature reviewed, there is no treatment which is both non-invasive and effective, and also could avoid recurrence well.

Extracorporeal shock wave therapy could induce angiogenesis, anti-inflammatory reaction, and recruitment of fibroblast. Although extracorporeal shock wave has been utilized in musculoskeletal diseases for more than twenty years, there is no well-designed clinical trial to prove the effectiveness of extracorporeal shock wave in treating trigger finger. The purpose of this study is to compare the effectiveness of extracorporeal shock wave therapy with traditional physical therapy for the management of trigger finger.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Extracorporeal Shock Wave in the Treatment of Trigger Finger

NCT03928873

Trigger Finger

UNKNOWN NA

Effectiveness of Conservative Interventions in the Treatment of Trigger Finger

NCT06296017

Trigger Finger Stenosing Tenosynovitis

RECRUITING NA

ESWT vs Orthosis in Trigger Finger

NCT06737601

Trigger Finger

NOT_YET_RECRUITING NA

Efficacy of Focused Shockwave Therapy in Patients With CTS

NCT05253729

Carpal Tunnel Syndrome

COMPLETED NA

Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)

NCT01184586

Dupuytren Contracture

UNKNOWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trigger Finger Stenosing Tenosynovitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Our study design is mainly to compare the therapeutic effect to trigger finger between extracorporeal shock wave (PiezoWave2 ECO, produced by Richard Wolf) and traditional physiotherapy.

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Focused Extracorporeal Shock Wave Therapy (ESWT)

2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks

Group Type EXPERIMENTAL

Focused Extracorporeal Shock Wave Therapy (ESWT)

Intervention Type DEVICE

2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks

Physiotherapy

therapeutic ultrasound, 12 times in 3 weeks

Group Type ACTIVE_COMPARATOR

physiotherapy

Intervention Type DEVICE

therapeutic ultrasound, 12 times in 3 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Focused Extracorporeal Shock Wave Therapy (ESWT)

2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks

Intervention Type DEVICE

physiotherapy

therapeutic ultrasound, 12 times in 3 weeks

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Quinnel classification grade 2 or 3
* who has only one trigger

Exclusion Criteria

* who had ever treated the trigger finger
* who has other musculoskeletal disease of the upper limb
* who has severe coagulopathy disease
* who is pregnant
* who has arrhythmia or has a pacemaker
* there is sensory impairment, scar, edema at the trigger finger
* who has cognitive dysfunction

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes